What is the difference between all the forms of folate? Why choosing active folate instead of folic acid? The new Quatrefolic® video answers all your questions.
Folate is an essential vitamin needed throughout all our life. However, we are not equal in our way to transform food folate and folate supplements. All forms of folate, vitamin B9, are different. The active folate, as Quatrefolic®, is the most suitable for our bodies because it doesn’t require any kind of metabolization to benefit all.
Quatrefolic® the natural form of active folate
Quatrefolic® is the folate form of reference for dietary supplements. It guarantees the right dosage of biologically active folate and can immediately supports the reproductive stage, homocysteine metabolism and cardiovascular health, mood & brain functioning and much more.
DISCOVER ALL OUR LATEST NEWS
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event dedicated to exploring the potential of probiotic yeasts. This live session brought together leading experts to present the latest scientific insights and real-world applications of live yeasts in human health.
Redefining Joint Health: Gnosis by Lesaffre Showcases MyCondro™ at CMA Innovation Day
At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by Lesaffre, led by Jose Pinedo Rivera, Product Manager, had the opportunity to present MyCondro™ to an engaged audience of over 250 industry professionals. The session, titled “Keeping Pace with a Changing World: MyCondro™ Disrupts the Chondroitin Sulfate Market,” was well received, sparking interest and conversations around the future of joint health solutions.
Supplementation with Menaquinone-7 (as MenaQ7®) Slows the Progression of Coronary Artery Calcification
The first results from the VitaK-CAC Trial, “Menaquinone-7 Slows Down Progression of Coronary Artery Calcification: A Randomized, Placebo-Controlled Trial,” were presented at the 34th European Meeting on Hypertension and Cardiovascular Protection, organized by the European Society of Hypertension (ESH), held in Milan in May 23–26, 2025.
